Chemoprevention of prostate cancer with finasteride

Expert Opinion on Pharmacotherapy
Edith D Canby-HaginoIan M Thompson

Abstract

Prostate cancer is a significant cause of disease and death, making it an attractive target for chemoprevention. The association between lifetime exposure to dihydrotestosterone and risk of developing prostate cancer suggests that chemoprevention is possible with 5alpha-reductase inhibition. The recently completed Prostate Cancer Prevention Trial indicates that chemoprevention is possible with the 5alpha-reductase inhibitor finasteride. Development of a cost-effective chemoprevention strategy for prostate cancer is evolving, and is expected to have significant positive economic and public health benefits.

References

Mar 1, 1992·The Journal of Clinical Endocrinology and Metabolism·J D McConnellE Stoner
Oct 22, 1992·The New England Journal of Medicine·G J GormleyJ S Tenover
Oct 1, 1992·The Journal of Clinical Endocrinology and Metabolism·J Imperato-McGinleyE Kazam
Dec 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J Geller
Jan 13, 1994·The New England Journal of Medicine·R S Rittmaster
Jun 1, 1995·Controlled Clinical Trials·P FeiglL G Ford
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G J Gormley
Feb 1, 1996·The Journal of Clinical Endocrinology and Metabolism·R S RittmasterG Rowden
Aug 21, 1996·Journal of the National Cancer Institute·P H GannM J Stampfer
Mar 30, 1999·Urology·L S MarksJ B deKernion
Dec 10, 1999·International Journal of Cancer. Journal International Du Cancer·A W HsingS S Devesa
Dec 22, 1999·The Journal of Clinical Endocrinology and Metabolism·J D Wilson, C Roehrborn
Jul 18, 2000·Pharmacogenetics·N M MakridakisJ K Reichardt
Nov 17, 2001·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·A LukanovaR Kaaks
Dec 26, 2001·Urology·W D Steers
Dec 20, 2002·Current Opinion in Urology·Charlotte L Foley, Roger S Kirby
Feb 8, 2003·Molecular and Cellular Endocrinology·J Imperato-McGinley, Y-S Zhu
May 30, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Christopher J BowmanPaul M D Foster
Jun 26, 2003·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Jul 29, 2003·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·R KaaksP Stattin
Nov 11, 2003·Urology·Angelo M De MarzoWilliam G Nelson
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Pär StattinMatti Hakama
Dec 19, 2003·The New England Journal of Medicine·John D McConnellUNKNOWN Medical Therapy of Prostatic Symptoms (MTOPS) Research Group
Jan 10, 2004·The Journal of Urology·Nick M Makridakis, Juergen K V Reichardt
Jan 30, 2004·The New England Journal of Medicine·Ernani Luis Rhoden, Abraham Morgentaler
Mar 17, 2004·Controlled Clinical Trials·Phyllis J GoodmanIan M Thompson
May 28, 2004·The New England Journal of Medicine·Ian M ThompsonCharles A Coltman
Jan 22, 2005·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yair LotanScott M Lippman
Jul 14, 2005·Expert Opinion on Drug Safety·Paul J Goodnick
Aug 9, 2005·The American Journal of Medicine·Steven B ZeliadtScott D Ramsey

❮ Previous
Next ❯

Citations

Sep 6, 2007·The Journal of Clinical Investigation·Russel S TaichmanKenneth J Pienta
Dec 29, 2007·Pharmaceutical Development and Technology·Rajiv KumarOm Prakash Katare
Jul 9, 2009·Cancer Prevention Research·Frank L Meyskens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
Ian M ThompsonC A Coltman
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Robert S SvatekYair Lotan
© 2022 Meta ULC. All rights reserved